ECLECL
US • —
$280.19
P/E
37.91
PEG
63.19
FCF Yield
—
Rev Growth YoY
+4.9% YoY
Gross Margin
44.4%
Health Score
7/10
D/E Ratio
0.84
Confidence
LOW
Business Snapshot
The company operates in the water, hygiene, and infection prevention solutions sector, serving customers in food service, hospitality, healthcare, and industrial markets. It holds a dominant competitive position as a global leader in commercial cleaning and water treatment services. The company's market cap tier and TTM revenue are not available in the data provided. A defining characteristic of this business is its recurring revenue model, built on long-term service contracts for consumable chemicals, equipment, and monitoring systems, which provides a degree of revenue visibility.
Financial Health
Gross margin stands at 44.4% and net margin is 12.8%, though year-over-year margin comparisons are unavailable in the provided data. The balance sheet is healthy with a debt-to-equity ratio of 0.84x, indicating moderate leverage, while the current ratio of 1.08x signals adequate short-term liquidity...
Risk Assessment
- VALUATION — P/E of 37.91x is well above the sector average of 22x, implying the stock trades at a significant premium that may not be supported by fundamentals.
- EARNINGS QUALITY — 0 out of 4 recent quarters beat estimates, signalling weak earnings consistency and low management guidance credibility.
- GROWTH DISCONNECT — Revenue grew 4.9% YoY but earnings grew only 0.6%, indicating margin pressure and a lack of operating leverage.
- TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed....
Gross margin stands at 44.4% and net margin is 12.8%, though year-over-year margin comparisons are unavailable in the provided data. The balance sheet is healthy with a debt-to-equity ratio of 0.84x, indicating moderate leverage, while the current ratio of 1.08x signals adequate short-term liquidity. Return on equity is strong at 21.7%, suggesting efficient capital use. Free cash flow is not available, preventing a direct assessment of cash generation or yield. Overall, the financial health appears solid, supported by reasonable margins, manageable debt, and strong profitability, which supports reinvestment and operational stability.
- VALUATION — P/E of 37.91x is well above the sector average of 22x, implying the stock trades at a significant premium that may not be supported by fundamentals. - EARNINGS QUALITY — 0 out of 4 recent quarters beat estimates, signalling weak earnings consistency and low management guidance credibility. - GROWTH DISCONNECT — Revenue grew 4.9% YoY but earnings grew only 0.6%, indicating margin pressure and a lack of operating leverage. - TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed.
Unlock the full AI report
Full 8-section analysis includes:
Metric deep-dives